Recombinant factor VIIa (rFVIIa) its effective at massive bleeding after caesarean section - A case report

被引:0
|
作者
Sokolic, V
Bukovic, D
Fures, R
Zadro, M
Scuric, I
Colak, F
Celovec, K
Bocan, A
机构
[1] Univ Zagreb, Ctr Hosp, Dept Obstet & Gynecol, Zagreb 10000, Croatia
[2] Gen Hosp Zabok, Dept Anesthesiol & Intens Care Med, Zabok, Croatia
[3] Ctr Hlth Zabok, Zabok, Croatia
关键词
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
A case of 31-year old woman who underwent emergency caesarean section (CS) following suspicion of the HELLP syndrome was reported. She developed arterial hypertension in 33(rd) week. In 38(th) week of her gestation elevated liver enzymes and positive albumin in urine were reported and pathological flow in umbilical artery and fetal aorta was found on ultrasound. The HELLP score was 12 and the HELLP syndrome was diagnosed. The pregnancy was terminated by CS for fetal distress and the HELLP syndrome. Two hours after the section she developed massive uterine bleeding with the signs of hemorrhagic shock. Despite of replacement therapy laboratory data worsened. DIC was diagnosed. Recombinant factor VIM was administrated; after several minutes bleeding decreased and laboratory data normalized.
引用
收藏
页码:155 / 157
页数:3
相关论文
共 50 条
  • [1] Successful use of recombinant factor VIIa for massive bleeding after Caesarean section due to HELLP syndrome
    Salek, SZ
    Sokolic, V
    Viskovic, T
    Sanjug, J
    Simic, M
    Kastelan, M
    ACTA HAEMATOLOGICA, 2002, 108 (03) : 162 - 163
  • [2] Glanzmann's thrombasthenia-case report of effective therapy with recombinant factor VIIa (rFVIIa) for bleeding and surgery
    Ceglarek, B.
    Bykowska, K.
    Maslanka, K.
    Misiak, A.
    Dabrowski, W.
    Szczepanik, A.
    Windyga, J.
    HAEMOPHILIA, 2013, 19 : 72 - 72
  • [3] Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
    Warkentin, Theodore E.
    Margetts, Peter
    Connolly, Stuart J.
    Lamy, Andre
    Ricci, Chris
    Eikelboom, John W.
    BLOOD, 2012, 119 (09) : 2172 - 2174
  • [4] Treatment of massive gastrointestinal bleeding in anaphilactoid purpura (Henoch-Schonlein) (HSP) with recombinant factor VIIa (rFVIIa)
    Puseljic, S.
    Milas, V.
    Zibar, L.
    Puseljic, I.
    Izakovic, S.
    Sipl, M.
    Berecki, I.
    Turjak, N.
    NEUROLOGIA CROATICA, 2005, 54 : 75 - 82
  • [5] Use of recombinant factor VIIa (rFVIIa) for bleeding and surgery in patients with Glanzmann thrombasthenia
    Poon, MC
    Demers, C
    Jobin, F
    Wu, JWY
    THROMBOSIS AND HAEMOSTASIS, 1999, : 745 - 745
  • [6] Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent
    Ulla Hedner
    Nikolai C. Brun
    Neuroradiology, 2007, 49 : 789 - 793
  • [7] Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent
    Hedner, Ulla
    Brun, Nikolai C.
    NEURORADIOLOGY, 2007, 49 (10) : 789 - 793
  • [8] Role of Recombinant Activated Factor VIIa (rFVIIa) in Bleeding Mycotic Aneurysm of the Abdominal Aorta
    Cetgen, Nurgul
    Ener, Dilek
    Dogukan, Mevlut
    Uludag, Oznur
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (09): : 1209 - 1211
  • [9] RECOMBINANT FACTOR-VIIA (RFVIIA) REDUCES THE BLEEDING-TIME IN PATIENTS WITH THROMBOCYTOPENIA
    KRISTENSEN, J
    KILLANDER, A
    HIPPE, E
    ELLEGAARD, J
    HEDNER, U
    BLOOD, 1993, 82 (10) : A155 - A155
  • [10] USE OF RECOMBINANT FACTOR VIIA (rFVIIa) IN ACUTE LIFE THREATENING PRIMARY POSTPARTUM HAEMORRHAGE: A CASE REPORT
    Quigley, J.
    Byrne, J.
    Diaz, M.
    Culliton, M.
    Murphy, K.
    Regan, I
    Doyle, B.
    Flannelly, G.
    VOX SANGUINIS, 2013, 105 : 272 - 273